Trial: 202111009

A Multicenter, Open-label, Phase 1 Study Evaluating The Safety and Tolerability of HMPL-760 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Other Non-Hodgkin Lymphoma (NHL)

Phase

I

Principal Investigator

Kahl, Brad

Disease Site

Lymphoid Leukemia; Non-Hodgkin Lymphoma

Learn more about this study at: clinicaltrials.gov